Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 32 (9), 769-774
- https://doi.org/10.1016/s1590-8658(00)80353-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1995
- Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.Gut, 1993
- Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.Gut, 1993
- Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's diseaseDigestive Diseases and Sciences, 1992
- Long-term effects of elemental and exclusion diets for Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1991
- Coated oral 5‐aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1990
- Remission induced by an elemental diet in small bowel Crohn's disease.Archives of Disease in Childhood, 1987
- Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.BMJ, 1984
- Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's diseaseDigestive Diseases and Sciences, 1981
- Corticosteroid or corticotrophin therapy in Crohn's disease (regional enteritis)Gut, 1970